Literature DB >> 10450102

Diagnosis of anaplastic large-cell lymphoma, including multifocal osseous KI-1 lymphoma, by fine-needle aspiration biopsy.

K Liu1, L G Dodd, B M Osborne, S Martinez, B A Olatdioye, J F Madden.   

Abstract

We present the fine-needle aspiration (FNA) findings of 4 cases of anaplastic (Ki-1) large-cell lymphoma (ALCL). A primary diagnosis of ALCL was made on FNA material in 2 cases, of which one was a multifocal osseous Ki-1 lymphoma. In the other 2 patients who had a known history of ALCL, FNA was used to detect recurrent disease. In all cases, large discohesive pleomorphic cells in the absence of lymphoglandular bodies in the background raised the possibility of a nonhematopoietic neoplasm. Immunochemical staining for CD30 was positive in all cases. The cytomorphologic and immunochemical features are discussed, along with the differential diagnosis of Ki-1 lymphoma. Diagn. Cytopathol. 1999;21:174-179. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450102     DOI: 10.1002/(sici)1097-0339(199909)21:3<174::aid-dc6>3.0.co;2-q

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  3 in total

1.  ALK-negative anaplastic large cell lymphoma mimicking a soft tissue sarcoma.

Authors:  Rachel Hudacko; Amy Rapkiewicz; Russell Scott Berman; Aylin Simsir
Journal:  J Cytol       Date:  2011-10       Impact factor: 1.000

2.  Fine needle aspiration cytology in the evaluation of lymphoid lesions: a retrospective study of the utility of flow cytometry in conjunction with morphology.

Authors:  Emad M Said Raddaoui; Lubna Sayage-Rabie; Robert S Beissner
Journal:  Ann Saudi Med       Date:  2012 Mar-Apr       Impact factor: 1.526

3.  Scope of FNAC in the diagnosis of soft tissue tumors--a study from a tertiary cancer referral center in India.

Authors:  Bharat Rekhi; Biru D Gorad; Anagha C Kakade; Rf Chinoy
Journal:  Cytojournal       Date:  2007-10-31       Impact factor: 2.091

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.